In today's Partnerships In Clinical Trials countdown, we look at the Databank Open House bonus session.
It will take place Monday, April 22 at 7:30AM. We're excited to kick off the conference highlighting partnerships between competitors in the industry. Elise Felicione, Director, Clinical Trial Innovation at Janssen Pharmaceuticals; Laura Galuchie, Director, Global Trial Management and Therapeutic Area Lead for Respiratory & Immunology at Merck and Michael Luker, Sr. Advisor, Clinical Research Innovation at Eli Lilly will be joining us for this session.
They'll look at how their pharmaceutical companies working with each other to promote the advancement of drug development. Fueled by a technology connecting drug researchers across the globe, the group has started an Open Investigator Databank initiative – a cross-pharmaceutical Investigator Databank with the mission to make it easier for drug makers to locate up-to-date information on clinical trial investigators and sites, and avoid duplicating efforts along the way.
This is the first unveiling of this partnership! We hope you can join us Monday morning!
If you're not registered to join us next week, as a reader of this blog when you register to join us and mention code XP1800BLOG, you'll save 15% off the standard rate! Have any questions? Feel free to email me at firstname.lastname@example.org.
The Partnerships in Clinical Trials Blog focuses on optimization intelligence, regulatory trends and globalization strategies for both sponsors and CROs. It is supported by a number of industry events.
Would you like to guest blog on our site? Or send us feedback? Send an email to email@example.com.